ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study

Jennifer A Doherty, Mary Anne Rossing, Kara L Cushing-Haugen, Chu Chen, David J Van Den Berg, Anna H Wu, Malcolm C Pike, Roberta B Ness, Kirsten Moysich, Georgia Chenevix-Trench, Jonathan Beesley, Penelope M Webb, Jenny Chang-Claude, Shan Wang-Gohrke, Marc T Goodman, Galina Lurie, Pamela J Thompson, Michael E Carney, Estrid Hogdall, Susanne Kruger KjaerClaus Hogdall, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Robert A Vierkant, Andrew Berchuck, Patricia G Moorman, Joellen M Schildkraut, Rachel T Palmieri, Daniel W Cramer, Kathryn L Terry, Hannah P Yang, Montserrat Garcia-Closas, Stephen Chanock, Jolanta Lissowska, Honglin Song, Paul D P Pharoah, Mitul Shah, Barbara Perkins, Valerie McGuire, Alice S Whittemore, Richard A Di Cioccio, Aleksandra Gentry-Maharaj, Usha Menon, Simon A Gayther, Susan J Ramus, Argyrios Ziogas, Wendy Brewster, Hoda Anton-Culver, Celeste Leigh Pearce, Australian Ovarian Cancer Study Management Group

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences